ubenimex has been researched along with Acute Myelogenous Leukemia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Wang, D; Wang, T; Xi, Y; Zhang, XE | 1 |
| Adachi, Y; Kimura, Y; Kiyoi, H; Komatsu, H; Kubo, K; Miyawaki, S; Miyazaki, Y; Naoe, T; Ohnishi, K; Ohno, R; Ohtake, S; Takada, S; Takeshita, A; Ueda, R; Wakita, A; Yagasaki, F; Yamaguchi, T; Yoshida, M | 1 |
| Chiba, H; Hirayama, Y; Matsunaga, T; Niitsu, Y; Sagawa, T; Sakamaki, S; Takayanagi, N; Tsuji, Y | 1 |
| Arimori, S; Komatsuda, M; Nagao, T; Shimizu, Y; Watanabe, K | 1 |
| Mizoguchi, H; Mutoh, Y; Ogawa, N; Takaku, F; Urabe, A | 1 |
| Ito, S; Miyairi, Y; Murai, K; Narigasawa, Y; Numaoka, H; Oikawa, H; Ono, Y; Shimosegawa, K; Sugawara, T; Utsugisawa, T | 1 |
| Abe, F; Fujii, H; Maruyama, S; Yosizawa, K | 1 |
| Hiraoka, A; Masaoka, T; Shibata, H | 1 |
| Ota, K | 1 |
| Ogawa, N; Ota, K | 1 |
| Ishikawa, T; Nagai, K; Nakayama, S; Yabe, H | 1 |
| Miura, K; Sawa, T; Takeuchi, T; Umezawa, H | 1 |
| Mishina, H; Okuyama, S | 1 |
1 review(s) available for ubenimex and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Review of ubenimex (Bestatin): clinical research.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Humans; Leucine; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms; Prospective Studies | 1991 |
5 trial(s) available for ubenimex and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia: the JALSG GML200 Study.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Female; Humans; Induction Chemotherapy; Leucine; Leukemia, Myeloid, Acute; Male; Survival Analysis; Treatment Outcome | 2012 |
Ubenimex in the treatment of acute nonlymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leucine; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction | 1993 |
Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Chronic Disease; Female; Graft vs Host Disease; Graft vs Host Reaction; Humans; Infant; Leucine; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Recurrence | 1992 |
Review of ubenimex (Bestatin): clinical research.
Topics: Adolescent; Adult; Age Factors; Antibiotics, Antineoplastic; Humans; Leucine; Leukemia, Myeloid, Acute; Middle Aged; Neoplasms; Prospective Studies | 1991 |
Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Topics: Adolescent; Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Follow-Up Studies; Humans; Leucine; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction | 1990 |
8 other study(ies) available for ubenimex and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Quantitative profiling of CD13 on single acute myeloid leukemia cells by super-resolution imaging and its implication in targeted drug susceptibility assessment.
Topics: Antibodies; Apoptosis; CD13 Antigens; Cell Cycle Checkpoints; Cell Line, Tumor; Humans; Leucine; Leukemia, Myeloid, Acute; Microscopy, Confocal; Quantum Dots | 2019 |
[Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].
Topics: Aclarubicin; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leucine; Leukemia, Myeloid, Acute; Male; Remission Induction; Survival Rate | 2003 |
The effect of bestatin on patients with acute and chronic leukemia and malignant lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Leucine; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged | 1980 |
[Hematological stability under ubenimex monotherapy in a patient with acute myelogenous leukemia developing marrow karyotypic changes during the course].
Topics: Aged; Antibiotics, Antineoplastic; Bone Marrow Cells; Chromosomes, Human, Pair 10; Chromosomes, Human, Pair 8; Female; Humans; Karyotyping; Leucine; Leukemia, Myeloid, Acute; Mutagenesis, Insertional; Trisomy | 1995 |
[Growth inhibitory effects of ubenimex on leukemic cell lines resistant to chemotherapeutic agents].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Division; Cytarabine; Daunorubicin; Depression, Chemical; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leucine; Leukemia, Myeloid, Acute; Mercaptopurine; Tumor Cells, Cultured | 1996 |
[Bestatin-induced intravascular hemolysis in a patient with acute myelocytic leukemia].
Topics: Acute Disease; Adjuvants, Immunologic; Adolescent; Anemia, Hemolytic; Female; Hemolysis; Humans; Leucine; Leukemia, Myeloid, Acute | 1990 |
Effects of enzyme inhibitors in inhibiting the growth and inducing the differentiation of human promyelocytic leukemia cells, HL-60.
Topics: Anti-Bacterial Agents; Cell Differentiation; Cell Line; Enzyme Inhibitors; Glycine; Guanidines; Humans; Leucine; Leukemia, Myeloid, Acute; Oligopeptides; Peptides; Protease Inhibitors | 1986 |
Principia of cancer therapy. XI. Prostaglandin D2 induces redifferentiation of M1 leukemia cells in vitro irrespective of bestatin.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Leucine; Leukemia, Myeloid, Acute; Mice; Prostaglandin D2; Prostaglandins D | 1985 |